Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
Clinical trial NCT05207514 · TERMINATED
Trial details
- NCT number
- NCT05207514
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2024-02-07
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.